| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
Divisions of 1 Biochemistry and 2 Animal Science, Chiba Cancer Center Research Institute; 3 Center for Functional Genomics, Hisamitsu Pharmaceutical Co., Inc., Chiba, Japan and 4 Department of Pathology, Gunma University School of Medicine, Gunma, Japan
Requests for reprints: Akira Nakagawara, Division of Biochemistry, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuoh-ku, Chiba 260-8717, Japan. Phone: 81-43-264-5431; Fax: 81-43-265-4459; E-mail: akiranak{at}chiba-cc.jp.
LIM-only proteins (LMO), which consist of LMO1, LMO2, LMO3, and LMO4, are involved in cell fate determination and differentiation during embryonic development. Accumulating evidence suggests that LMO1 and LMO2 act as oncogenic proteins in T-cell acute lymphoblastic leukemia, whereas LMO4 has recently been implicated in the genesis of breast cancer. However, little is known about the role of LMO3 in either tumorigenesis or development. In the present study, we have identified LMO3 and HEN2, which encodes a neuronal basic helix-loop-helix protein, as genes whose expression levels were higher in unfavorable neuroblastomas compared with those of favorable tumors. Immunoprecipitation and immunostaining experiments showed that LMO3 was associated with HEN2 in mammalian cell nucleus. Human neuroblastoma SH-SY5Y cells stably overexpressing LMO3 showed a marked increase in cell growth, a promotion of colony formation in soft agar medium, and a rapid tumor growth in nude mice compared with the control transfectants. More importantly, the increased expression of LMO3 and HEN2 was significantly associated with a poor prognosis in 87 primary neuroblastomas. These results suggest that the deregulated expression of neuronal-specific LMO3 and HEN2 contributes to the genesis and progression of human neuroblastoma in a lineage-specific manner.
This article has been cited by other articles:
|
|
 |
|
  A. Panner, C. A. Crane, C. Weng, A. Feletti, A. T. Parsa, and R. O. Pieper A Novel PTEN-Dependent Link to Ubiquitination Controls FLIPS Stability and TRAIL Sensitivity in Glioblastoma Multiforme Cancer Res., October 15, 2009; 69(20): 7911 - 7916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fassunke, M. Majores, A. Tresch, P. Niehusmann, A. Grote, S. Schoch, and A. J. Becker Array analysis of epilepsy-associated gangliogliomas reveals expression patterns related to aberrant development of neuronal precursors Brain, November 1, 2008; 131(11): 3034 - 3050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zenvirt, Y. Nevo-Caspi, S. Rencus-Lazar, and D. Segal Drosophila LIM-Only Is a Positive Regulator of Transcription During Thoracic Bristle Development Genetics, August 1, 2008; 179(4): 1989 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Fox and D. J. Good Nescient Helix-Loop-Helix 2 Interacts with Signal Transducer and Activator of Transcription 3 to Regulate Transcription of Prohormone Convertase 1/3 Mol. Endocrinol., June 1, 2008; 22(6): 1438 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Xu, X. Meng, Y. Cai, H. Liang, L. Nagarajan, and S. J. Brandt Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins Genes & Dev., April 15, 2007; 21(8): 942 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Singh, C. J. Barnes, A. H. Talukder, S. A.W. Fuqua, and R. Kumar Negative Regulation of Estrogen Receptor {alpha} Transactivation Functions by LIM Domain Only 4 Protein Cancer Res., November 15, 2005; 65(22): 10594 - 10601. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
